Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	61,713	89,210	79,951	72,791	52,964	45,307
Cash & Short-Term Investments	61,713	89,210	79,951	72,791	52,964	45,307
Cash Growth	-24.63%	11.58%	9.84%	37.43%	16.90%	19.68%
Receivables	73,880	69,115	60,656	51,682	47,865	50,416
Inventory	61,255	46,657	41,062	33,527	27,925	30,625
Other Current Assets	8,597	9,777	8,577	6,306	4,317	3,760
Total Current Assets	205,445	214,759	190,246	164,306	133,071	130,108
Property, Plant & Equipment	86,824	68,607	66,182	62,839	49,790	48,460
Long-Term Investments	48,077	43,731	32,629	27,471	27,425	24,024
Goodwill	46,017	2,285	2,564	2,954	4,014	3,373
Other Intangible Assets	8,539	6,932	6,997	6,338	3,521	1,945
Long-Term Deferred Tax Assets	-	3,869	5,371	5,297	4,606	4,292
Other Long-Term Assets	8,957	2	1	2	2	2
Total Assets	403,859	346,175	309,677	274,627	225,790	215,301
Accounts Payable	20,277	21,123	18,718	16,269	11,330	14,243
Accrued Expenses	22,724	25,720	24,362	19,354	25,208	28,312
Short-Term Debt	21,018	5,304	4,177	8,033	2,312	2,105
Current Income Taxes Payable	5,452	6,643	6,230	3,185	6,138	5,728
Other Current Liabilities	37,201	28,297	26,675	24,647	11,483	11,729
Total Current Liabilities	106,672	87,087	80,162	71,488	56,471	62,117
Long-Term Debt	17,788	5,190	7,516	13,350	5,787	5,190
Long-Term Deferred Tax Liabilities	-	1,597	1,173	1,450	639	373
Other Long-Term Liabilities	9,527	2,720	2,645	1,177	2,831	3,274
Total Liabilities	136,683	99,142	94,600	90,797	69,179	75,271
Common Stock	6,504	6,504	6,504	6,504	6,504	6,504
Additional Paid-In Capital	-	4,516	5,292	5,787	5,661	5,661
Retained Earnings	221,983	209,399	184,005	162,195	145,511	131,985
Treasury Stock	-4,939	-4,939	-4,938	-4,936	-4,936	-4,935
Comprehensive Income & Other	32,520	30,843	18,706	8,737	3,167	66
Total Common Equity	256,068	246,323	209,569	178,287	155,907	139,281
Minority Interest	11,108	710	5,508	5,543	704	749
Shareholders' Equity	267,176	247,033	215,077	183,830	156,611	140,030
Total Liabilities & Equity	403,859	346,175	309,677	274,627	225,790	215,301
Total Debt	38,806	10,494	11,693	21,383	8,099	7,295
Net Cash (Debt)	22,907	78,716	68,258	51,408	44,865	38,012
Net Cash Growth	-68.29%	15.32%	32.78%	14.58%	18.03%	16.29%
Net Cash Per Share	100.12	344.04	298.33	224.69	196.09	166.15
Filing Date Shares Outstanding	228.14	228.14	228.14	228.14	228.14	228.14
Total Common Shares Outstanding	228.14	228.14	228.14	228.14	228.14	228.14
Working Capital	98,773	127,672	110,084	92,818	76,600	67,991
Book Value Per Share	1122.42	1079.71	918.60	781.48	683.38	610.51
Tangible Book Value	201,512	237,106	200,008	168,995	148,372	133,963
Tangible Book Value Per Share	883.29	1039.31	876.69	740.75	650.35	587.20

Source: S&P Capital IQ. Standard template. Financial Sources.